128 related articles for article (PubMed ID: 37031411)
1. Markers of inflammasome activation in Coronavirus disease 2019 (COVID-19) Egyptian patients: Impact on disease severity.
Abd El-Aty SK; Ahmed SH; Abd El-Hamid RF; Zahran AM; Magdy DM; Bakr OH; Elsherbiny NM
Egypt J Immunol; 2023 Apr; 30(2):99-108. PubMed ID: 37031411
[TBL] [Abstract][Full Text] [Related]
2. IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding.
Markovic SS; Jovanovic M; Gajovic N; Jurisevic M; Arsenijevic N; Jovanovic M; Jovanovic M; Mijailovic Z; Lukic S; Zornic N; Vukicevic V; Stojanovic J; Maric V; Jocic M; Jovanovic I
Front Med (Lausanne); 2021; 8():749569. PubMed ID: 34917631
[No Abstract] [Full Text] [Related]
3. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study).
Abd El-Ghani SE; Hamed RMR; Eid RA; Ibrahim AYM; Abdel-Hamid HM; Abdelrahman W; Ibrahim RE; Abdel-Aziz MM; Mohamed MS
Thromb J; 2022 Dec; 20(1):77. PubMed ID: 36522776
[TBL] [Abstract][Full Text] [Related]
5. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
6. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.
Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G
J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093
[TBL] [Abstract][Full Text] [Related]
10. The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19.
Al-Juboori RSF; Al-Bayaa YJ
Egypt J Immunol; 2024 Apr; 31(2):93-101. PubMed ID: 38615266
[TBL] [Abstract][Full Text] [Related]
11. Correlations between Cytokine Levels, Liver Function Markers, and Neuropilin-1 Expression in Patients with COVID-19.
El Kazafy SA; Fouad YM; Said AF; Assal HH; Ali TM; Ahmed AE; Elesawy BH; Ahmed OM
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298501
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study.
Salem ML; Eltoukhy MM; Shalaby RE; Okasha KM; El-Shanshoury MR; Attia MA; Hantera MS; Hilal A; Eid MA
J Interferon Cytokine Res; 2023 Jun; 43(6):257-268. PubMed ID: 37252793
[TBL] [Abstract][Full Text] [Related]
13. Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients.
Adamik B; Ambrożek-Latecka M; Dragan B; Jeznach A; Śmiechowicz J; Gożdzik W; Skirecki T
Shock; 2022 May; 57(5):672-679. PubMed ID: 35583911
[TBL] [Abstract][Full Text] [Related]
14. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease.
Wang H; Lv C; Wang S; Ying H; Weng Y; Yu W
Inflammation; 2018 Aug; 41(4):1321-1333. PubMed ID: 29656319
[TBL] [Abstract][Full Text] [Related]
16. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
[TBL] [Abstract][Full Text] [Related]
17. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
Rodrigues TS; de Sá KSG; Ishimoto AY; Becerra A; Oliveira S; Almeida L; Gonçalves AV; Perucello DB; Andrade WA; Castro R; Veras FP; Toller-Kawahisa JE; Nascimento DC; de Lima MHF; Silva CMS; Caetite DB; Martins RB; Castro IA; Pontelli MC; de Barros FC; do Amaral NB; Giannini MC; Bonjorno LP; Lopes MIF; Santana RC; Vilar FC; Auxiliadora-Martins M; Luppino-Assad R; de Almeida SCL; de Oliveira FR; Batah SS; Siyuan L; Benatti MN; Cunha TM; Alves-Filho JC; Cunha FQ; Cunha LD; Frantz FG; Kohlsdorf T; Fabro AT; Arruda E; de Oliveira RDR; Louzada-Junior P; Zamboni DS
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33231615
[TBL] [Abstract][Full Text] [Related]
18. The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.
Volfovitch Y; Tsur AM; Gurevitch M; Novick D; Rabinowitz R; Mandel M; Achiron A; Rubinstein M; Shoenfeld Y; Amital H
Immunol Res; 2022 Dec; 70(6):817-828. PubMed ID: 36222965
[TBL] [Abstract][Full Text] [Related]
19. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
Sahin O; Aktoz F; Bagci H; Vurgun E
J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
[TBL] [Abstract][Full Text] [Related]
20. Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner.
Yang Z; Cao J; Yu C; Yang Q; Zhang Y; Han L
Joint Bone Spine; 2016 May; 83(3):282-9. PubMed ID: 26775759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
